Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029
The single-use assemblies market is expected to grow to USD 4.89 billion by 2029, up from USD 2.63 billion in 2024, at a CAGR of 13.2% between 2024 and 2029. Growth in this market is mainly driven by the growing adoption among CDMOs, SMEs & startups, rapid implementation and low risk of cross-contamination, growing biologics & biosimilar markets, and cost savings with single-use assemblies. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the focus on capacity expansion by biopharmaceutical companies is expected to drive the market further.
“The 2D bag assemblies segment accounted for the largest share of bag assemblies segment for the single-use assemblies market in 2023.”
The bag assemblies segment of the single-use assemblies market is further divided into 2D & 3D bag assemblies. In 2023, the 2D bag assemblies segment accounted for the largest share of the global single-use assemblies market by bag assemblies. The dominance of 2D bag assemblies over 3D assemblies can be attributed to their simpler design, ease of handling, and suitability for lower-volume operations. Additionally, their ability to integrate seamlessly into automated systems and compatibility with a range of fluids, such as buffers and reagents, makes them a preferred choice for manufacturers.
“The monoclonal antibodies segment accounted for the largest share of by modalities segment for the single-use assemblies market in 2023.”
In 2023, the monoclonal antibodies segment accounted for the largest share of the global single-use assemblies market by modality. Monoclonal antibodies (mAbs) are one of the largest segments of the biotechnology drugs market. Factors The large share of the monoclonal antibodies (mAbs) segment can be attributed to the increasing demand for single-use assemblies in the manufacturing of mAbs due to low capital investment, low workforce requirements, and reductions in time-consuming changeover procedures and validation.
“In 2023, the US remained to dominate the single-use assemblies market.”
The US dominated the North American single-use assemblies market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing support from government bodies in the form of funds and grants is also driving the growth of the single-use assemblies market.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other
executives from various key organizations operating in the single-use assemblies
marketplace.
The study includes an in-depth competitive analysis of these key players in the single-use assemblies market, with their company profiles, recent developments, and key market strategies
Research Coverage:
This research report categorizes the single-use assemblies market by product ( bag assemblies {2D bag assemblies and 3D bag assemblies}, filtration assemblies, bottle assemblies, tubing assemblies, mixing assemblies, sampling assemblies, sensor assemblies, and other single-use assembly products), solution (standard solutions and customized solutions), modality (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies), application (filtration & purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation & fill-finish applications, and mixing), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use assemblies market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-use assemblies market.
Reasons to buy this report
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-use assemblies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The 2D bag assemblies segment accounted for the largest share of bag assemblies segment for the single-use assemblies market in 2023.”
The bag assemblies segment of the single-use assemblies market is further divided into 2D & 3D bag assemblies. In 2023, the 2D bag assemblies segment accounted for the largest share of the global single-use assemblies market by bag assemblies. The dominance of 2D bag assemblies over 3D assemblies can be attributed to their simpler design, ease of handling, and suitability for lower-volume operations. Additionally, their ability to integrate seamlessly into automated systems and compatibility with a range of fluids, such as buffers and reagents, makes them a preferred choice for manufacturers.
“The monoclonal antibodies segment accounted for the largest share of by modalities segment for the single-use assemblies market in 2023.”
In 2023, the monoclonal antibodies segment accounted for the largest share of the global single-use assemblies market by modality. Monoclonal antibodies (mAbs) are one of the largest segments of the biotechnology drugs market. Factors The large share of the monoclonal antibodies (mAbs) segment can be attributed to the increasing demand for single-use assemblies in the manufacturing of mAbs due to low capital investment, low workforce requirements, and reductions in time-consuming changeover procedures and validation.
“In 2023, the US remained to dominate the single-use assemblies market.”
The US dominated the North American single-use assemblies market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing support from government bodies in the form of funds and grants is also driving the growth of the single-use assemblies market.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other
executives from various key organizations operating in the single-use assemblies
marketplace.
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
The study includes an in-depth competitive analysis of these key players in the single-use assemblies market, with their company profiles, recent developments, and key market strategies
Research Coverage:
This research report categorizes the single-use assemblies market by product ( bag assemblies {2D bag assemblies and 3D bag assemblies}, filtration assemblies, bottle assemblies, tubing assemblies, mixing assemblies, sampling assemblies, sensor assemblies, and other single-use assembly products), solution (standard solutions and customized solutions), modality (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies), application (filtration & purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation & fill-finish applications, and mixing), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use assemblies market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-use assemblies market.
Reasons to buy this report
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-use assemblies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (rising adoption of single-use assemblies in biopharmaceutical manufacturing, increasing focus on advantages of single-use solutions over traditional bioprocessing, booming biologics and biosimilars market, and growing advancements in single-use assembly technologies), restraints (issues related to leachables and extractables, complex and stringent regulatory landscape for single-use products, leakage and integrity issues), opportunities (high growth in emerging economies, rising focus on expanding bioprocessing capacities), and Challenges (standardization of single-use assemblies, waste generation and disposal issues, gap between demand and supply of single-use assemblies) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the single-use assemblies market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use assemblies market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc (US), Sartorius AG (Germany), Merck KGaA (Germany), Danaher Corporation (US), Avantor, Inc. (US), Parker Hannifin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entegris (US), among others in the market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET ESTIMATION
2.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.2.3 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SINGLE-USE ASSEMBLIES MARKET OVERVIEW
4.2 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION AND COUNTRY, 2023
4.3 SINGLE-USE ASSEMBLIES MARKET, BY END USER, 2024 VS. 2029
4.4 SINGLE-USE ASSEMBLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising adoption of single-use systems in biopharmaceutical manufacturing
5.2.1.2 Increasing focus on advantages of single-use solutions over traditional bioprocessing
5.2.1.3 Booming biologics and biosimilars market
5.2.1.4 Growing advancements in single-use assembly technologies
5.2.2 RESTRAINTS
5.2.2.1 Issues related to leachables and extractables
5.2.2.2 Complex and stringent regulatory landscape for single-use products
5.2.2.3 Leakage and integrity issues
5.2.3 OPPORTUNITIES
5.2.3.1 High growth in emerging economies
5.2.3.2 Rising focus on expanding bioprocessing capacities
5.2.4 CHALLENGES
5.2.4.1 Standardization of single-use assemblies
5.2.4.2 Waste generation and disposal issues
5.2.4.3 Gap between demand and supply of single-use assemblies
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 RAW MATERIAL SUPPLIERS
5.7.2 PRODUCT MANUFACTURERS
5.7.3 END USERS
5.7.4 REGULATORY BODIES
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Filtration
5.9.1.2 Cell culture
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.3 ADJACENT TECHNOLOGIES
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 392390
5.11.2 EXPORT DATA FOR HS CODE 392390
5.12 KEY CONFERENCES AND EVENTS
5.13 REGULATORY LANDSCAPE
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13.2 REGULATORY FRAMEWORK
5.13.2.1 North America
5.13.2.1.1 US
5.13.2.1.2 Canada
5.13.2.2 Europe
5.13.2.2.1 Germany
5.13.2.2.2 UK
5.13.2.3 Asia Pacific
5.13.2.3.1 Japan
5.13.2.3.2 China
5.13.2.4 Latin America
5.13.2.4.1 Brazil
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2 BUYING CRITERIA
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-USE ASSEMBLIES MARKET
5.16.1 INTRODUCTION
5.16.2 MARKET POTENTIAL FOR SINGLE-USE ASSEMBLIES
5.16.3 AI USE CASES
5.16.4 KEY COMPANIES IMPLEMENTING AI
5.16.5 FUTURE OF GENERATIVE AI ON SINGLE-USE ASSEMBLIES ECOSYSTEM
6 SINGLE-USE ASSEMBLIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 BAG ASSEMBLIES
6.2.1 2D BAG ASSEMBLIES
6.2.1.1 Growing use in buffer preparation, media storage, and harvest collection to fuel market
6.2.2 3D BAG ASSEMBLIES
6.2.2.1 Larger volume storage and transport capabilities to speed up growth
6.2.3 BAG ASSEMBLIES, BY APPLICATION
6.3 FILTRATION ASSEMBLIES
6.3.1 RISING FOCUS ON PREVENTING LOSSES AND MAINTAINING PRODUCT QUALITY TO BOOST MARKET
6.4 BOTTLE ASSEMBLIES
6.4.1 REDUCED DOWNTIME AND TURNAROUND TIME TO BOOST MARKET
6.4.2 BOTTLE ASSEMBLIES, BY APPLICATION
6.5 TUBING ASSEMBLIES
6.5.1 ENHANCED RISK MANAGEMENT AND PRODUCTION TO ENCOURAGE GROWTH
6.6 MIXING ASSEMBLIES
6.6.1 MINIMIZED OPERATOR EXPOSURE AND REDUCED DOWNTIME FOR CLEANING TO AID GROWTH
6.7 SAMPLING ASSEMBLIES
6.7.1 NEED FOR QUALITY CONTROL AND PROCESS MONITORING IN BIOPROCESSING TO AUGMENT GROWTH
6.8 SENSOR ASSEMBLIES
6.8.1 GROWING ADOPTION OF BIOPROCESSING AUTOMATION TO DRIVE MARKET
6.9 OTHER SINGLE-USE ASSEMBLY PRODUCTS
7 SINGLE-USE ASSEMBLIES MARKET, BY SOLUTION
7.1 INTRODUCTION
7.2 STANDARD SOLUTIONS
7.2.1 GROWING FOCUS ON CAPITAL COST AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET
7.3 CUSTOMIZED SOLUTIONS
7.3.1 NEED FOR ENHANCED PROCESS EFFICIENCY IN BIOPHARMACEUTICAL MANUFACTURING TO PROMOTE GROWTH
8 SINGLE-USE ASSEMBLIES MARKET, BY MODALITY
8.1 INTRODUCTION
8.2 MONOCLONAL ANTIBODIES
8.2.1 INCREASING POPULARITY OF TARGETED THERAPY TO PROMOTE GROWTH
8.3 VACCINES
8.3.1 ONGOING NEED TO ADDRESS GLOBAL HEALTH CHALLENGES TO AUGMENT GROWTH
8.4 THERAPEUTIC PROTEINS & PEPTIDES
8.4.1 GROWING SHIFT TOWARD BIOLOGIC TREATMENTS AND PERSONALIZED MEDICINES TO BOOST MARKET
8.5 CELL & GENE THERAPIES
8.5.1 RISING R&D INITIATIVES AND COLLABORATIONS AMONG KEY PLAYERS TO FACILITATE GROWTH
9 SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 FILTRATION & PURIFICATION APPLICATIONS
9.2.1 INCREASING FOCUS ON MANUFACTURING AFFORDABLE BIOPHARMACEUTICALS TO SPUR GROWTH
9.3 ASEPTIC TRANSFER
9.3.1 GROWING DEMAND FOR BIOLOGICS AND CELL & GENE THERAPIES TO FUEL MARKET
9.4 STORAGE APPLICATIONS
9.4.1 NEED FOR FLEXIBLE AND SCALABLE STORAGE OPTIONS TO CONTRIBUTE TO GROWTH
9.5 SAMPLING APPLICATIONS
9.5.1 INCREASING COMPLEXITY IN BIOLOGICS MANUFACTURING TO ENCOURAGE GROWTH
9.6 CELL CULTURE
9.6.1 GROWING INVESTMENTS IN SINGLE-USE BIOPROCESSING INFRASTRUCTURE TO BOOST MARKET
9.7 FORMULATION & FILL-FINISH APPLICATIONS
9.7.1 GROWING TREND OF OUTSOURCING TO PROPEL MARKET
9.8 MIXING APPLICATIONS
9.8.1 PRE-STERILIZED DESIGN AND AUTOMATED DESIGNS TO ACCELERATE GROWTH
10 SINGLE-USE ASSEMBLIES MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.2.1 RISING PRODUCTION OF BIOLOGICS AND BIOSIMILARS TO SUSTAIN GROWTH
10.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
10.3.1 GROWING PREFERENCE FOR OUTSOURCING RESEARCH AND MANUFACTURING ACTIVITIES TO STIMULATE GROWTH
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 INCREASING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO FUEL MARKET
11 SINGLE-USE ASSEMBLIES MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Highly advanced infrastructure and private funding to facilitate growth
11.2.3 CANADA
11.2.3.1 Increasing government support for biologics manufacturing to expedite growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 High government R&D investment and facility expansions by key players to aid growth
11.3.3 UK
11.3.3.1 Increased production of novel therapies, devices, and diagnostics to stimulate growth
11.3.4 FRANCE
11.3.4.1 Rising number of research collaborations and healthcare investments to sustain growth
11.3.5 ITALY
11.3.5.1 Increasing investment in advanced biomanufacturing facilities to spur growth
11.3.6 SPAIN
11.3.6.1 Increasing development of targeted therapies to contribute to growth
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Low manufacturing costs and high investments in biotechnology sector to encourage growth
11.4.3 SOUTH KOREA
11.4.3.1 Evolving pharmaceutical manufacturing market to accelerate growth
11.4.4 JAPAN
11.4.4.1 Robust regulatory framework and technological expertise to favor growth
11.4.5 INDIA
11.4.5.1 Low labor cost and availability of skilled professionals to propel market
11.4.6 AUSTRALIA
11.4.6.1 Increased investments in clinical trials to augment growth
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Increasing adoption of cell & gene therapies to promote growth
11.5.3 MEXICO
11.5.3.1 Growing foreign direct investments to boost market
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
11.6.2 GCC COUNTRIES
11.6.2.1 Saudi Arabia
11.6.2.1.1 Growing investments in healthcare infrastructure and research to fuel market
11.6.2.2 UAE
11.6.2.2.1 Rising focus on developing life science products to support growth
11.6.2.3 Rest of GCC countries
11.6.3 REST OF MIDDLE EAST
11.7 AFRICA
11.7.1 GROWING DEMAND FOR CRITICAL DRUGS TO DRIVE MARKET
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE ASSEMBLIES MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Solution footprint
12.5.5.5 Application footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION AND FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 SARTORIUS AG
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Deals
13.1.2.3.2 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 MERCK KGAA
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 DANAHER CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 AVANTOR, INC.
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.3.2 Expansions
13.1.6 PARKER HANNIFIN CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Expansions
13.1.7 SAINT-GOBAIN
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches
13.1.7.3.2 Deals
13.1.7.3.3 Expansions
13.1.8 REPLIGEN CORPORATION
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.8.3.2 Expansions
13.1.9 CORNING INCORPORATED
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 ENTEGRIS
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Expansions
13.1.11 LONZA
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 ZACROS CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Expansions
13.1.13 W. L. GORE & ASSOCIATES, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.2 OTHER PLAYERS
13.2.1 NEWAGE INDUSTRIES
13.2.2 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
13.2.3 COBETTER
13.2.4 ANTYLIA SCIENTIFIC
13.2.5 NUPORE FILTRATION SYSTEMS
13.2.6 INTELLITECH, INC.
13.2.7 MEISSNER FILTRATION PRODUCTS, INC.
13.2.8 SANISURE
13.2.9 SENTINEL PROCESS SYSTEMS INC.
13.2.10 FLUID FLOW PRODUCTS, INC.
13.2.11 DOVER CORPORATION
13.2.12 KEOFITT A/S
13.2.13 CELLEXUS
13.2.14 FOXX LIFE SCIENCES
13.2.15 TSE INDUSTRIES, INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET ESTIMATION
2.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.2.3 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SINGLE-USE ASSEMBLIES MARKET OVERVIEW
4.2 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION AND COUNTRY, 2023
4.3 SINGLE-USE ASSEMBLIES MARKET, BY END USER, 2024 VS. 2029
4.4 SINGLE-USE ASSEMBLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising adoption of single-use systems in biopharmaceutical manufacturing
5.2.1.2 Increasing focus on advantages of single-use solutions over traditional bioprocessing
5.2.1.3 Booming biologics and biosimilars market
5.2.1.4 Growing advancements in single-use assembly technologies
5.2.2 RESTRAINTS
5.2.2.1 Issues related to leachables and extractables
5.2.2.2 Complex and stringent regulatory landscape for single-use products
5.2.2.3 Leakage and integrity issues
5.2.3 OPPORTUNITIES
5.2.3.1 High growth in emerging economies
5.2.3.2 Rising focus on expanding bioprocessing capacities
5.2.4 CHALLENGES
5.2.4.1 Standardization of single-use assemblies
5.2.4.2 Waste generation and disposal issues
5.2.4.3 Gap between demand and supply of single-use assemblies
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.7.1 RAW MATERIAL SUPPLIERS
5.7.2 PRODUCT MANUFACTURERS
5.7.3 END USERS
5.7.4 REGULATORY BODIES
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Filtration
5.9.1.2 Cell culture
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.3 ADJACENT TECHNOLOGIES
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 392390
5.11.2 EXPORT DATA FOR HS CODE 392390
5.12 KEY CONFERENCES AND EVENTS
5.13 REGULATORY LANDSCAPE
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13.2 REGULATORY FRAMEWORK
5.13.2.1 North America
5.13.2.1.1 US
5.13.2.1.2 Canada
5.13.2.2 Europe
5.13.2.2.1 Germany
5.13.2.2.2 UK
5.13.2.3 Asia Pacific
5.13.2.3.1 Japan
5.13.2.3.2 China
5.13.2.4 Latin America
5.13.2.4.1 Brazil
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2 BUYING CRITERIA
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-USE ASSEMBLIES MARKET
5.16.1 INTRODUCTION
5.16.2 MARKET POTENTIAL FOR SINGLE-USE ASSEMBLIES
5.16.3 AI USE CASES
5.16.4 KEY COMPANIES IMPLEMENTING AI
5.16.5 FUTURE OF GENERATIVE AI ON SINGLE-USE ASSEMBLIES ECOSYSTEM
6 SINGLE-USE ASSEMBLIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 BAG ASSEMBLIES
6.2.1 2D BAG ASSEMBLIES
6.2.1.1 Growing use in buffer preparation, media storage, and harvest collection to fuel market
6.2.2 3D BAG ASSEMBLIES
6.2.2.1 Larger volume storage and transport capabilities to speed up growth
6.2.3 BAG ASSEMBLIES, BY APPLICATION
6.3 FILTRATION ASSEMBLIES
6.3.1 RISING FOCUS ON PREVENTING LOSSES AND MAINTAINING PRODUCT QUALITY TO BOOST MARKET
6.4 BOTTLE ASSEMBLIES
6.4.1 REDUCED DOWNTIME AND TURNAROUND TIME TO BOOST MARKET
6.4.2 BOTTLE ASSEMBLIES, BY APPLICATION
6.5 TUBING ASSEMBLIES
6.5.1 ENHANCED RISK MANAGEMENT AND PRODUCTION TO ENCOURAGE GROWTH
6.6 MIXING ASSEMBLIES
6.6.1 MINIMIZED OPERATOR EXPOSURE AND REDUCED DOWNTIME FOR CLEANING TO AID GROWTH
6.7 SAMPLING ASSEMBLIES
6.7.1 NEED FOR QUALITY CONTROL AND PROCESS MONITORING IN BIOPROCESSING TO AUGMENT GROWTH
6.8 SENSOR ASSEMBLIES
6.8.1 GROWING ADOPTION OF BIOPROCESSING AUTOMATION TO DRIVE MARKET
6.9 OTHER SINGLE-USE ASSEMBLY PRODUCTS
7 SINGLE-USE ASSEMBLIES MARKET, BY SOLUTION
7.1 INTRODUCTION
7.2 STANDARD SOLUTIONS
7.2.1 GROWING FOCUS ON CAPITAL COST AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET
7.3 CUSTOMIZED SOLUTIONS
7.3.1 NEED FOR ENHANCED PROCESS EFFICIENCY IN BIOPHARMACEUTICAL MANUFACTURING TO PROMOTE GROWTH
8 SINGLE-USE ASSEMBLIES MARKET, BY MODALITY
8.1 INTRODUCTION
8.2 MONOCLONAL ANTIBODIES
8.2.1 INCREASING POPULARITY OF TARGETED THERAPY TO PROMOTE GROWTH
8.3 VACCINES
8.3.1 ONGOING NEED TO ADDRESS GLOBAL HEALTH CHALLENGES TO AUGMENT GROWTH
8.4 THERAPEUTIC PROTEINS & PEPTIDES
8.4.1 GROWING SHIFT TOWARD BIOLOGIC TREATMENTS AND PERSONALIZED MEDICINES TO BOOST MARKET
8.5 CELL & GENE THERAPIES
8.5.1 RISING R&D INITIATIVES AND COLLABORATIONS AMONG KEY PLAYERS TO FACILITATE GROWTH
9 SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 FILTRATION & PURIFICATION APPLICATIONS
9.2.1 INCREASING FOCUS ON MANUFACTURING AFFORDABLE BIOPHARMACEUTICALS TO SPUR GROWTH
9.3 ASEPTIC TRANSFER
9.3.1 GROWING DEMAND FOR BIOLOGICS AND CELL & GENE THERAPIES TO FUEL MARKET
9.4 STORAGE APPLICATIONS
9.4.1 NEED FOR FLEXIBLE AND SCALABLE STORAGE OPTIONS TO CONTRIBUTE TO GROWTH
9.5 SAMPLING APPLICATIONS
9.5.1 INCREASING COMPLEXITY IN BIOLOGICS MANUFACTURING TO ENCOURAGE GROWTH
9.6 CELL CULTURE
9.6.1 GROWING INVESTMENTS IN SINGLE-USE BIOPROCESSING INFRASTRUCTURE TO BOOST MARKET
9.7 FORMULATION & FILL-FINISH APPLICATIONS
9.7.1 GROWING TREND OF OUTSOURCING TO PROPEL MARKET
9.8 MIXING APPLICATIONS
9.8.1 PRE-STERILIZED DESIGN AND AUTOMATED DESIGNS TO ACCELERATE GROWTH
10 SINGLE-USE ASSEMBLIES MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
10.2.1 RISING PRODUCTION OF BIOLOGICS AND BIOSIMILARS TO SUSTAIN GROWTH
10.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
10.3.1 GROWING PREFERENCE FOR OUTSOURCING RESEARCH AND MANUFACTURING ACTIVITIES TO STIMULATE GROWTH
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 INCREASING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO FUEL MARKET
11 SINGLE-USE ASSEMBLIES MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Highly advanced infrastructure and private funding to facilitate growth
11.2.3 CANADA
11.2.3.1 Increasing government support for biologics manufacturing to expedite growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 High government R&D investment and facility expansions by key players to aid growth
11.3.3 UK
11.3.3.1 Increased production of novel therapies, devices, and diagnostics to stimulate growth
11.3.4 FRANCE
11.3.4.1 Rising number of research collaborations and healthcare investments to sustain growth
11.3.5 ITALY
11.3.5.1 Increasing investment in advanced biomanufacturing facilities to spur growth
11.3.6 SPAIN
11.3.6.1 Increasing development of targeted therapies to contribute to growth
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Low manufacturing costs and high investments in biotechnology sector to encourage growth
11.4.3 SOUTH KOREA
11.4.3.1 Evolving pharmaceutical manufacturing market to accelerate growth
11.4.4 JAPAN
11.4.4.1 Robust regulatory framework and technological expertise to favor growth
11.4.5 INDIA
11.4.5.1 Low labor cost and availability of skilled professionals to propel market
11.4.6 AUSTRALIA
11.4.6.1 Increased investments in clinical trials to augment growth
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Increasing adoption of cell & gene therapies to promote growth
11.5.3 MEXICO
11.5.3.1 Growing foreign direct investments to boost market
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
11.6.2 GCC COUNTRIES
11.6.2.1 Saudi Arabia
11.6.2.1.1 Growing investments in healthcare infrastructure and research to fuel market
11.6.2.2 UAE
11.6.2.2.1 Rising focus on developing life science products to support growth
11.6.2.3 Rest of GCC countries
11.6.3 REST OF MIDDLE EAST
11.7 AFRICA
11.7.1 GROWING DEMAND FOR CRITICAL DRUGS TO DRIVE MARKET
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE ASSEMBLIES MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Solution footprint
12.5.5.5 Application footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION AND FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 SARTORIUS AG
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Deals
13.1.2.3.2 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 MERCK KGAA
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 DANAHER CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 AVANTOR, INC.
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.3.2 Expansions
13.1.6 PARKER HANNIFIN CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Expansions
13.1.7 SAINT-GOBAIN
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches
13.1.7.3.2 Deals
13.1.7.3.3 Expansions
13.1.8 REPLIGEN CORPORATION
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.8.3.2 Expansions
13.1.9 CORNING INCORPORATED
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.10 ENTEGRIS
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Expansions
13.1.11 LONZA
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 ZACROS CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Expansions
13.1.13 W. L. GORE & ASSOCIATES, INC.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.2 OTHER PLAYERS
13.2.1 NEWAGE INDUSTRIES
13.2.2 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
13.2.3 COBETTER
13.2.4 ANTYLIA SCIENTIFIC
13.2.5 NUPORE FILTRATION SYSTEMS
13.2.6 INTELLITECH, INC.
13.2.7 MEISSNER FILTRATION PRODUCTS, INC.
13.2.8 SANISURE
13.2.9 SENTINEL PROCESS SYSTEMS INC.
13.2.10 FLUID FLOW PRODUCTS, INC.
13.2.11 DOVER CORPORATION
13.2.12 KEOFITT A/S
13.2.13 CELLEXUS
13.2.14 FOXX LIFE SCIENCES
13.2.15 TSE INDUSTRIES, INC.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
